<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>TYPE 2 DIABETES MELLITUS: PATHOPHYSIOLOGY, CLINICAL PROGRESSION AND MODERN MANAGEMENT</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Tangriyeva Mohinur Hazratqul</mods:namePart><mods:namePart type="family">qizi</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Odiljonov Ozodbek Odiljon</mods:namePart><mods:namePart type="family">o‘g‘li</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Abdusamiyeva Nargiza</mods:namePart><mods:namePart type="family">Qudratovna</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Type 2 Diabetes Mellitus (T2DM) is a chronic progressive metabolic disorder characterized by insulin resistance and pancreatic beta-cell dysfunction. It represents one of the most significant global health burdens of the 21st century. This paper examines the epidemiology, pathophysiology, clinical manifestations, complications, diagnostic criteria, and contemporary treatment approaches of T2DM. The study is structured according to the IMRAD format and integrates current evidence-based guidelines.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-03-02</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>"Research Science and Innovation house" LLC</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>